Fast-rising drug prices hit hospitals hard in bottom lines
Skip to main content
MDHC_Logotype_white
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • This Week's News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • People
    • Regional News
    • Digital Edition
    • Health experts blame rapid expansion for vaccine shortages
      Profit up nearly 23% across U.S. community hospitals in 2019
      HHS freezes rule targeting community health centers' drug discounts
      Cerner names Erceg as new CFO
    • Health experts blame rapid expansion for vaccine shortages
      HCA launches joint venture to boost domestic PPE production
      Lilly: Drug can prevent COVID-19 illness in nursing homes
      Mobile labs take vaccine studies to diverse neighborhoods
    • Medicare ACO participants fell in 2021
      Louisiana gets reports vaccine providers are discriminating
      'We know this is real': New clinics aid virus 'long-haulers'
      The Check Up: Trenda Ray
      The Check Up: Trenda Ray of the University of Arkansas for Medical Sciences
    • UnitedHealthcare operating earnings fall by $2 billion in Q4
      CMS approves rule forcing insurers to ease prior authorization
      COVID-19 still a big uncertainty for insurers in 2021
      Health insurers' outlook boosted after Dems' Georgia win
    • Health experts blame rapid expansion for vaccine shortages
      HHS freezes rule targeting community health centers' drug discounts
      Biden signs executive orders to reverse, pause Trump-era rules
      CMS finalizes blood-based colon cancer screening coverage
    • Providers await new HHS coronavirus grant reporting deadline
      Operation Warp Speed Dr. Moncef Slaoui, Pfizer Group President Angela Hwang, Moderna CEO Stephane Bancel, CVS Health Executive Vice President Karen Lynch and McKesson CEO Brian Tyler participate in a panel discussion on the COVID-19 vaccine.
      Hospitals, drug companies strive to stand out virtually at JPM
      Intermountain, Trinity, Memorial Hermann behind $300M private equity fund
      Operation Warp Speed to bump up McKesson's stock price
    • A man in a room with servers.
      Momentum grows to outsource hospital tech functions in 2021
      5 things to know about Google's $2.1B Fitbit acquisition
      Providence bets on machine-learning, consolidating data centers
      Mental health treatment was most common telehealth service during COVID
    • Mobile labs take vaccine studies to diverse neighborhoods
      As virus surges, states reporting shortages of vaccine
      Sticking to Mediterranean diet is good for the brain
      Chance of COVID-19 triage care looms over Arizona hospitals
    • Cerner names Erceg as new CFO
      Elizabeth Richter will serve as acting CMS administrator
      Providence names new chief financial officer
      Wisconsin's top health official departing for federal job
    • Midwest
    • Northeast
    • South
    • West
  • Insights
    • ACA 10 Years After
    • Best Practices
    • InDepth Special Reports
    • Innovations
    • The Affordable Care Act after 10 years
    • New care model helps primary-care practices treat obesity
      doctor with patient
      COVID-19 treatment protocol developed in the field helps patients recover
      Rachel Wyatt
      Project to curb pressure injuries in hospitals shows promise
      Yale New Haven's COVID-19 nurse-staffing model has long-term benefits
    • Michellene Davis
      Healthcare leadership lacks the racial diversity needed to reduce health disparities
      Dr. James Hildreth
      How medical education can help fight racism
      Modern Healthcare InDepth: Breaking the bias that impedes better healthcare
      Videos: Healthcare industry executives describe their encounters with racism
      Quotes from rebadged employees
      Outsourcing IT, revenue cycle takes toll on internal culture
    • A woman with a wearable sensor talking to her provider.
      Wearable sensors help diagnose heart rhythm problems in West Virginia
      self service station
      COVID-19 pushes patient expectations toward self-service
      Targeting high-risk cancer patients with genetics
      A nurse holds up a phone with a message to a family member saying surgery has started.
      Texting, tablets help hospitals keep family updated on patient care
  • Transformation
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Highmark Health inks six-year cloud, tech deal with Google
      Study: 1 in 5 patients report discrimination when getting healthcare
      HHS proposes changing HIPAA privacy rules
      Android health records app launches at 230 health systems
    • California hospitals prepare ethical protocol to prioritize lifesaving care
      Amazon, JPMorgan Chase, Berkshire Hathaway disband Haven
      Digital pathways poised to reshape healthcare continuum in 2021
      Healthcare was the hardest hit by supply shortages across all U.S. industries
    • A woman with a wearable sensor talking to her provider.
      Wearable sensors help diagnose heart rhythm problems in West Virginia
      New care model helps primary-care practices treat obesity
      How hospitals are building on COVID-19 telehealth momentum
      Researchers: Hospital price variation exacerbates health inequities
    • MedPAC votes to boost hospital payments, freeze or cut other providers
      Most Next Gen ACOs achieved bonuses in 2019
      Congress recalibrates Medicare Physician Fee Schedule after lobbying
      CMS approves rule to encourage value-based drug pricing
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
    • Health Systems Financials
      Executive Compensation
      Physician Compensation
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
    • Wellstar CEO calls adapting for the pandemic her bold move
      Howard P. Kern
      Recognizing the value of telehealth in its infancy
      Dr. Stephen Markovich
      A bold move helped take him from family doctor to OhioHealth CEO
      Dr. Bruce Siegel
      Why taking a hospital not-for-profit was Dr. Bruce Siegel’s boldest move
    • Barry Ostrowsky
      Ending racism is a journey taken together; the starting point must be now
      Laura Lee Hall and Gary Puckrein
      Increased flu vaccination has never been more important for communities of color
      John Daniels Jr.
      Health equity: Making the journey from buzzword to reality
      Mark C. Clement and David Cook
      We all need to 'do something' to fight inequities and get healthcare right, for every patient, every time
    • Dr. Bruce Siegel
      By protecting the healthcare safety net, Biden can put us on the path to a stronger country
      Healing healthcare: some ideas for triage by the new Congress, administration
      Dr. Sachin H. Jain
      Medicare for All? The better route to universal coverage would be Medicare Advantage for All
      Connectivity: a social determinant of health that can exacerbate all the others
    • Letters: Eliminating bias in healthcare needs to be ‘deliberate and organic’
      Letters: Maybe dropping out of ACOs is a good thing for patients
      Letters: White House and Congress share blame for lack of national COVID strategy
      Letters: VA making strides to improve state veterans home inspections
    • Sponsored Content Provided By Optum
      How blockchain could ease frustration with the payment process
      Sponsored Content Provided By Optum
      Three steps to better data-sharing for payer and provider CIOs
      Sponsored Content Provided By Optum
      Reduce total cost of care: 6 reasons why providers and payers should tackle the challenge together
      Sponsored Content Provided By Optum
      Why CIOs went from back-office operators to mission-critical innovators
  • Awards
    • Award Programs
    • Nominate
    • Previous Award Programs
    • Other Award Programs
    • Best Places to Work in Healthcare Logo for Navigation
      Nominations Open - Best Places to Work in Healthcare
      Nominations Open - Health Care Hall of Fame
      Nominations Open - 50 Most Influential Clinical Executives
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Top 25 Minority Leaders
    • Top 25 Women Leaders
    • Excellence in Nursing Awards
    • Design Awards
    • Top 25 COOs in Healthcare
    • 100 Top Hospitals
    • ACHE Awards
  • Events
    • Conferences
    • Galas
    • Webinars
    • COVID-19 Event Tracker
    • Leadership Symposium
    • Healthcare Transformation Summit
    • Women Leaders in Healthcare Conference
    • Workplace of the Future Conference
    • Strategic Marketing Conference
    • Social Determinants of Health Symposium
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Minority Leaders Gala (2022)
    • Top 25 Women Leaders Gala
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
    • Carter Dredge
      Next Up Podcast: Ready, set, innovate! Innovation and disruption in healthcare
      Next Up Podcast: COVID-19, social determinants highlight health inequities — what next?
      Ceci Connolly
      Next Up Podcast: How to navigate the murky post-election waters
      Next Up Podcast: Saving Rural Health
    • An older man wearing a mask receiving a vaccine.
      Beyond the Byline: Verifying information on the chaotic COVID-19 vaccine rollout
      doctor burnout
      Beyond the Byline: How healthcare supply chain struggles contribute to employee burnout
      Beyond the Byline: Covering race and diversity in the healthcare industry
      Beyond the Byline: How telehealth utilization has impacted investor-owned company earnings
    • Leading intention promote diversity and inclusion
      Introducing Healthcare Insider Podcast
    • The Check Up: Chip Kahn
      The Check Up: Chip Kahn of the Federation of American Hospitals
      The Check Up: Trenda Ray
      The Check Up: Trenda Ray of the University of Arkansas for Medical Sciences
      The Check Up: Dr. Kenneth Davis
      The Check Up: Dr. Kenneth Davis of Mount Sinai Health System
      The Check Up: Dr. Thomas McGinn
      The Check Up: Dr. Thomas McGinn of CommonSpirit Health
    • Video: Ivana Naeymi Rad of Intelligent Medical Objects
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Providers
June 13, 2016 01:00 AM

Fast-rising drug prices hit hospitals hard in bottom lines

Jay Greene, Crain's Detroit Business
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print

    When drug costs rose $20 million in one year for Beaumont Health in suburban Detroit, CEO John Fox asked executives like Kathy Pawlicki, vice president for pharmacy, why and what could be done about it.

    The answer? Not much. Leading factors for drug price increases are mostly out of providers' control, including such recent trends as hedge funds acquiring generic-drug companies and then forcing up prices.

    Double-digit price increases have not affected just hospitals, but also clinics, insurers and retail pharmacies, experts said.

    Bob Kirby, corporate director for Chicago-based Fitch Ratings, said prices of such injectable heart medications as Nitropress and Isuprel doubled after Valeant Pharmaceuticals acquired the parent companies last year.

    Pfizer, Amgen, Allergan, Horizon Pharma and others have raised U.S. prices by up to 10 percent for dozens of branded drugs since last fall. Some drug prices might be discounted with rebates offered to insurers, other payers and group purchasing organizations.

    "We are seeing specialty pharma firms buying products or companies and then jacking up the price significantly," Kirby said. "In some cases, consolidation is driving up the increases. Some drugs used in hospitals are only manufactured by a small number of companies."

    Total U.S. prescription-drug spending rose 12.2 percent in 2015, accelerating from 2.4 percent growth in 2014, the Centers for Medicare and Medicaid Services said.

    But rising drug costs also can be attributed to an increased volume of patients because of Healthy Michigan Medicaid expansion, an improving economy and newer specialty, biotech and personalized medicine drugs, Pawlicki said.

    "We have really seen significant increases the past few years. Last year was just intensified and much larger than in the past," Pawlicki said.

    Last year, Beaumont spent about $250 million for pharmaceuticals, but this year costs are projected to rise above $270 million, an 8 percent increase, she said.

    "The majority of the price increases are for existing drugs, but we also are paying higher prices than usual for newer biotech drugs that are coming into the market," she said. "We have approved 13 new biotech drugs, and we estimate spending about $14.3 million. This is to treat 476 patients, usually in an infusion center, for a chronic disease or oncology."

    Executives at St. John Providence Health System and St. Joseph Mercy Health System in Ann Arbor also confirm high drug prices are becoming a problem. St. John's average pharmacy prices are up 13 percent this year, and St. Joe's projects more than a 10 percent increase, up from 5 to 7 percent in recent years, executives said.

    Generics made only by a single source, such as Daraprim, are increasing in price without warning due to lack of competition, said Chris Cook, St. Joseph Mercy's regional director of pharmacy.

    "Specialty medications for complex disease states such as HIV or cancer are high-technological products and very expensive," said Cook, adding that oncology medications are "not only expensive but the utilization is rising as we get better at detecting and treating more cancers."

    Experts project that by 2020, specialty drugs will make up 50 percent of all medication costs nationally, including hospital, retail and clinics, rising from $98 billion spent in 2016 to $212 billion in 2020.

    Last year, the Food and Drug Administration approved 45 novel medicines for marketing. Biologics accounted for 12 of the 2015 approvals versus 10 during 2014. More than half were drugs to treat cancer (33 percent), cardiovascular disease (17 percent) and infections (8 percent).

    In May, Pfizer agreed to acquire Anacor Pharmaceuticals for $5.2 billion to gain control over its eczema treatment, Crisaborole, which has projected annual sales of $2 billion. But U.S. regulators recently nixed the merger of Pfizer and Allergan.

    Other recent targeted transactions include Bristol-Myers Squibb's acquisition of Padlock Therapeutics, which could expand its presence in the treatment of rheumatoid arthritis, and Eli Lilly's acquisition of Glycostasis Inc., which is seeking to develop a form of insulin that self-releases when a diabetic patient's blood sugar level is too high. In addition, Merck bought IOmet earlier this year, adding new immune-oncology technology to its portfolio.

    Will the high prices continue?

    Kirby said he believes some drug companies will be hard-pressed to justify or demonstrate additional value that higher prices might warrant because the drugs have been on the market for some time.

    "They claim the drug is so significantly undervalued they had to jack up the price a multiple of times," Kirby said.

    Because of the increased scrutiny from Congress and the media, Kirby doubts that drug companies will be able to continue to increase prices.

    Several national organizations, such as the Campaign for Sustainable Rx Pricing, The American Society of Health System Pharmacists and the American Association of Retired Persons, have mounted strong campaigns against high drug prices.

    "I am critical of how and what is going on in the pharmaceutical industry," Pawlicki said. "There are a number of examples where manufacturers have increased costs without demonstrating any sudden change in the value of drugs."

    But Kirby added that some newer specialty drugs for oncology and hepatitis are being priced significantly higher than their predecessors.

    "If a drug has been around for 20 years, it shouldn't be priced 500 percent more today," Pawlicki said. "There are some drugs that benefit patients immensely. They reduce hospital length of stay and improve conditions."

    For example, the Hepatitis C specialty medicine, which can cost up to $100,000 a year to treat patients, has proven value, Pawlicki said. "These drugs (Sovaldi, Olysio or Harvoni) cure and can save money over time as patients don't have to be chronically treated for two years," she said.

    Pawlicki said drug prices appear to have stabilized the past few months but haven't dropped. "Valeant held back some further price increases and promises some retooling, but I haven't seen anything yet," she said.

    Meanwhile, executives at Beaumont, St. Joseph Mercy and St. John have taken steps to more effectively manage costs and supplies.

    "It's challenging and costly both for health care organizations and the patients and families who need the medications," Pawlicki said.

    Hospital systems and medical staffs are coaching doctors and patients about best use of pharmaceuticals and when to use generics or other alternative therapies.

    "We are looking heavily at clinical evidence to make sure we are utilizing appropriate clinical medicine and keeping doctors abreast of pricing," Pawlicki said. "We are working alternatives and looking at our formularies, leveraging supply contracts, using different-size vials, a whole host of things to reduce expenses."

    Cook said because St. Joseph Mercy is part of Novi-based Trinity Health, bulk purchasing helps minimize costs compared with smaller hospitals or health organizations. Trinity operates 90 hospitals nationally, including 11 in Michigan.

    "We created a task force to identify the most cost-effective drugs, utilization strategies and dispensing practices across our five-hospital system," said Cook, noting the effort will save several hundred thousand dollars.

    "We continuously look for drug alternatives and advanced utilization strategies to maintain cost effectiveness without sacrificing quality and safety," Cook said.

    Pawlicki said hospitals are capped at how much they can charge payers like Medicare and Medicaid for higher drug costs. In outpatient settings, however, patients absorb the higher costs, she said.

    "If treatment is at an infusion center or self administered at home, the reimbursement is a little different," she said. "Reimbursement may or may not cover the costs. If a patient obtains meds through outpatient pharmacy, the patient pays out of pocket" for the price increase.

    But Pawlicki said Beaumont — like most other hospitals — have special programs to help lower income patients pay for higher-priced drugs. Last year, Beaumont helped 206 patients get access to free or drug company rebates that were worth about $2.4 million, she said.

    "Fast-rising drug prices hit hospitals hard in bottom lines" originally appeared in Crain's Detroit Business.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Medicare ACO participants fell in 2021
    Medicare ACO participants fell in 2021
    Louisiana gets reports vaccine providers are discriminating
    Louisiana gets reports vaccine providers are discriminating
    Sponsored Content
    Get Free Newsletters

    Sign up for free enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today

    The weekly magazine, websites, research and databases provide a powerful and all-encompassing industry presence. We help you make informed business decisions and lead your organizations to success.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS
    • Instagram

    Stay Connected

    Join the conversation with Modern Healthcare through our social media pages

    MDHC_Logotype_white
    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2021. Crain Communications, Inc. All Rights Reserved.
    • News
      • This Week's News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition
    • Insights
      • ACA 10 Years After
      • Best Practices
      • InDepth Special Reports
      • Innovations
    • Transformation
      • Patients
      • Operations
      • Care Delivery
      • Payment
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Award Programs
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Top 25 Minority Leaders
        • Top 25 Women Leaders
      • Nominate
      • Previous Award Programs
        • Excellence in Nursing Awards
        • Design Awards
        • Top 25 COOs in Healthcare
      • Other Award Programs
        • 100 Top Hospitals
        • ACHE Awards
    • Events
      • Conferences
        • Leadership Symposium
        • Healthcare Transformation Summit
        • Women Leaders in Healthcare Conference
        • Workplace of the Future Conference
        • Strategic Marketing Conference
        • Social Determinants of Health Symposium
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Minority Leaders Gala (2022)
        • Top 25 Women Leaders Gala
      • Webinars
      • COVID-19 Event Tracker
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing